What Is It?
Five peptides that researchers report don't build tolerance — your body doesn't adapt and the effects don't fade. Called the "daily driver stack" in the longevity research community.
How Does It Work?
Most peptides work by pushing your body harder — and after a while, your body pushes back. Receptors adapt. Effects fade. These five work differently. Instead of pushing you past baseline, they restore what you should already have. Your body doesn't adapt to having what it needs.
Compounds Covered
- BPC-157 — Gut healing and tissue repair. Restores mucosal protection.
- GHK-Cu — Copper peptide. Restores collagen, gene activation. Levels naturally decline 60% by age 60.
- Thymosin Alpha-1 — Immune thermostat. Restores T-cell training capacity. Approved in 35+ countries.
- Epitalon — Telomere and pineal support. Restores melatonin production.
- KPV — Anti-inflammatory tripeptide. Restores NF-kB balance.
Run the Numbers
Plan a daily-driver stack with our calculator — concentration, daily totals, and stack overlap. Free, no login required.
Open the Calculator →The Honest Part
- "Lowest tolerance risk in research" is not "zero tolerance proven."
- Decades of continuous human use data don't exist for any of them.
- Only Thymosin Alpha-1 has regulatory approval (in 35+ countries, not US).
- All others are research compounds.
- For research purposes only.
Research Sources
Verified vendors offering this compound for research purposes. Use the vendor-specific code shown on each card for discounts. We may earn commissions from these links.
Track Your Forever Stack in the App
Peptide Manager Pro tracks 100+ compounds with an interactive knowledge graph, dosing calculator, protocol tracker, and AI research chat. Veteran-owned. $4.99/mo founding rate.
Get the App →